4.4 Article

Influence of the NRGN gene on intellectual ability in schizophrenia

期刊

JOURNAL OF HUMAN GENETICS
卷 58, 期 10, 页码 700-705

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/jhg.2013.82

关键词

diplotype; GWAS; NRGN; performance IQ; schizophrenia

资金

  1. Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-001]
  2. Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22390225]
  3. CREST of JST
  4. Japan Foundation for Neuroscience and Mental Health

向作者/读者索取更多资源

Genome-wide association studies have reported an association between schizophrenia and rs12807809 of the neurogranin (NRGN) gene. We have recently found that an rs12807809-rs12278912 haplotype of the gene is associated with schizophrenia in a Japanese population and that the NRGN expression of the high-risk TG haplotype is lower than that of the protective TA haplotype in immortalized lymphoblasts. In this study, we investigated the influences of neurogranin genotypes (rs12807809 and rs12278912), haplotypes and diplotypes and genetic variant-diagnosis interactions on intellectual ability in 414 Japanese patients with schizophrenia and healthy subjects. We detected possible effects of the genome-wide screen-supported rs12807809, haplotypes, diplotypes and their genetic variant-diagnosis interactions on intellectual abilities at the threshold level of P<0.05. After applying Bonferroni correction for 13 genotype measures and setting P-values for significance (P<0.0039; 0.05/13), three effects remained significant: the rs12807809-rs12278912 diplotype-diagnosis interactions on performance intelligence quotient (CG/CG: P=3.9 x 10(-13); TA/TA: P=1.1 x 10(-7)) and TA/TA diplotype on performance intelligence quotient in patients with schizophrenia (P=8.2 x 10(-8)) remained significant. The intellectual abilities of the high-risk TG/TG diplotype of the neurogranin gene were lower compared to those with the non-risk TA/TA diplotype. Our findings suggest that the genetic risk variant in the neurogranin gene may be related to reduced intellectual ability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Shared genetic etiology between anxiety disorders and psychiatric and related intermediate phenotypes

Kazutaka Ohi, Takeshi Otowa, Mihoko Shimada, Tsukasa Sasaki, Hisashi Tanii

PSYCHOLOGICAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals

Daisuke Koshiyama, Masaki Fukunaga, Naohiro Okada, Kentaro Morita, Kiyotaka Nemoto, Kaori Usui, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Noriko Kudo, Hirotsugu Azechi, Yoshiyuki Watanabe, Naoki Hashimoto, Hisashi Narita, Ichiro Kusumi, Kazutaka Ohi, Takamitsu Shimada, Yuzuru Kataoka, Maeri Yamamoto, Norio Ozaki, Go Okada, Yasumasa Okamoto, Kenichiro Harada, Koji Matsuo, Hidenori Yamasue, Osamu Abe, Ryuichiro Hashimoto, Tsutomu Takahashi, Tomoki Hori, Masahito Nakataki, Toshiaki Onitsuka, Laurena Holleran, Neda Jahanshad, Theo G. M. van Erp, Jessica Turner, Gary Donohoe, Paul M. Thompson, Kiyoto Kasai, Ryota Hashimoto

MOLECULAR PSYCHIATRY (2020)

Article Clinical Neurology

Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants

Kazutaka Ohi, Daisuke Nishizawa, Takamitsu Shimada, Yuzuru Kataoka, Junko Hasegawa, Toshiki Shioiri, Yasuhiro Kawasaki, Ryota Hashimoto, Kazutaka Ikeda

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Article Psychiatry

Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project

Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, Shuhei Ishikawa, Shusuke Numata, Hikaru Hori, Hitoshi Iida, Kayo Ichihashi, Ryuji Furihata, Atsunobu Murata, Takashi Tsuboi, Masahiro Takeshima, Yoshitaka Kyou, Hiroshi Komatsu, Chika Kubota, Shinichiro Ochi, Yoshikazu Takaesu, Masahide Usami, Tatsuya Nagasawa, Akitoyo Hishimoto, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Hisashi Yamada, Ken Inada, Koichiro Watanabe, Kazutaka Shimoda, Ryota Hashimoto

Summary: The analysis of discharge prescription data for patients with schizophrenia and MDD revealed differences in prescription patterns for antipsychotics and hypnotics/anxiolytics among patients of different age groups, as well as the common practice of polypharmacy.

ASIAN JOURNAL OF PSYCHIATRY (2021)

Article Neurosciences

Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder

Itaru Kushima, Masahiro Nakatochi, Branko Aleksic, Takashi Okada, Hiroki Kimura, Hidekazu Kato, Mako Morikawa, Toshiya Inada, Kanako Ishizuka, Youta Torii, Yukako Nakamura, Satoshi Tanaka, Miho Imaeda, Nagahide Takahashi, Maeri Yamamoto, Kunihiro Iwamoto, Yoshihiro Nawa, Nanayo Ogawa, Shuji Iritani, Yu Hayashi, Tzuyao Lo, Gantsooj Otgonbayar, Sho Furuta, Nakao Iwata, Masashi Ikeda, Takeo Saito, Kohei Ninomiya, Tomo Okochi, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Kenichiro Miura, Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita, Kazuya Toriumi, Kazutaka Ohi, Toshiki Shioiri, Kiyoyuki Kitaichi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Tsukasa Sasaki, Mamoru Tochigi, Fumichika Nishimura, Hidenori Yamasue, Hitoshi Kuwabara, Tomoyasu Wakuda, Takahiro A. Kato, Shigenobu Kanba, Hideki Horikawa, Masahide Usami, Masaki Kodaira, Kyota Watanabe, Takeo Yoshikawa, Tomoko Toyota, Shigeru Yokoyama, Toshio Munesue, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Minyoung Jung, Kiyoto Kasai, Tempei Ikegame, Seiichiro Jinde, Shusuke Numata, Makoto Kinoshita, Tadafumi Kato, Chihiro Kakiuchi, Kazuhiro Yamakawa, Toshimitsu Suzuki, Naoki Hashimoto, Shuhei Ishikawa, Bun Yamagata, Shintaro Nio, Toshiya Murai, Shuraku Son, Yasuto Kunii, Hirooki Yabe, Masumi Inagaki, Yu-ichi Goto, Yuto Okumura, Tomoya Ito, Yuko Arioka, Daisuke Mori, Norio Ozaki

Summary: This study aimed to compare the roles of genic and regulatory copy number variations (CNVs) in bipolar disorder (BD), schizophrenia (SCZ), and autism spectrum disorder (ASD). High-resolution CNV data from 8708 Japanese samples were used to perform the largest cross-disorder analysis of genic and regulatory CNVs in these disorders. The results showed differences in CNV burden, characteristics of CNVs associated with neurodevelopmental disorders, and regulatory CNVs between BD and SCZ/ASD. However, there were also shared molecular mechanisms, particularly in chromatin biology. The study identified specific risk genes for BD that could contribute to understanding the pathogenesis of the disorder.

BIOLOGICAL PSYCHIATRY (2022)

Article Psychiatry

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project

Hisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Norio Yasui-Furukori, Shusuke Numata, Masahiro Takeshima, Nobuhiro Sugiyama, Tatsuya Nagasawa, Chika Kubota, Kiyokazu Atake, Takashi Tsuboi, Kayo Ichihashi, Naoki Hashimoto, Takahiko Inagaki, Yoshikazu Takaesu, Jun-ichi Iga, Hikaru Hori, Toshiaki Onitsuka, Hiroshi Komatsu, Akitoyo Hishimoto, Kentaro Fukumoto, Michiko Fujimoto, Toshinori Nakamura, Kiyotaka Nemoto, Ryuji Furihata, Satoshi Yamamura, Hirotaka Yamagata, Kazuyoshi Ogasawara, Eiichi Katsumoto, Atsunobu Murata, Hitoshi Iida, Shinichiro Ochi, Manabu Makinodan, Mikio Kido, Taishiro Kishimoto, Yuka Yasuda, Masahide Usami, Taro Suwa, Ken Inada, Koichiro Watanabe, Ryota Hashimoto

Summary: This study aimed to assess the effectiveness of the EGUIDE project on the clinical behavior of psychiatrists in accordance with clinical practice guidelines. The results showed that the EGUIDE program significantly improved the clinical behaviors of psychiatrists in accordance with guidelines, and these improvements were sustained for at least 2 years.

BJPSYCH OPEN (2022)

Article Psychiatry

Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study

Chika Sumiyoshi, Kazutaka Ohi, Haruo Fujino, Hidenaga Yamamori, Michiko Fujimoto, Yuka Yasuda, Yota Uno, Junichi Takahashi, Kentaro Morita, Asuka Katsuki, Maeri Yamamoto, Yuko Okahisa, Ayumi Sata, Eiichi Katsumoto, Michihiko Koeda, Yoji Hirano, Masahito Nakataki, Junya Matsumoto, Kenichiro Miura, Naoki Hashimoto, Manabu Makinodan, Tsutomu Takahashi, Kiyotaka Nemoto, Toshifumi Kishimoto, Michio Suzuki, Tomiki Sumiyoshi, Ryota Hashimoto

Summary: This study classified individuals with mental disorders based on intellectual abilities and work outcomes, highlighting the effectiveness of transdiagnostic approaches and emphasizing the importance of diagnosis-specific strategies to support functional recovery in people with mental disorders.

BJPSYCH OPEN (2022)

Article Psychology, Clinical

Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach

Kazutaka Ohi, Daisuke Nishizawa, Shunsuke Sugiyama, Kentaro Takai, Daisuke Fujikane, Ayumi Kuramitsu, Junko Hasegawa, Midori Soda, Kiyoyuki Kitaichi, Ryota Hashimoto, Kazutaka Ikeda, Toshiki Shioiri

Summary: Individuals with schizophrenia and bipolar disorder commonly experience cognitive impairments. Genetic risk plays a role in the cognitive impairments of schizophrenia. Cognitive performances differ among individuals with different genetic risks.

PSYCHOLOGICAL MEDICINE (2023)

Correction Psychiatry

Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (vol 12, 278, 2022)

Klaus Oliver Schubert, Anbupalam Thalamuthu, Azmeraw T. Amare, Joseph Frank, Fabian Streit, Mazda Adl, Nirmala Akula, Kazufumi Akiyama, Raffaella Ardau, Barbara Arias, Jean-Michel Aubry, Lena Backlund, Abesh Kumar Bhattacharjee, Frank Bellivier, Antonio Benabarre, Susanne Bengesser, Joanna M. Biernacka, Armin Birner, Cynthia Marie-Claire, Micah Cearns, Pablo Cervantes, Hsi-Chung Chen, Caterina Chillotti, Sven Cichon, Scott R. Clark, Cristiana Cruceanu, Piotr M. Czerski, Nina Dalkner, Alexandre Dayer, Franziska Degenhardt, Maria Del Zompo, J. Raymond DePaulo, Bruno Etain, Peter Falkai, Andreas J. Forstner, Louise Frisen, Mark A. Frye, Janice M. Fullerton, Sebastien Gard, Julie S. Garnham, Fernando S. Goes, Maria Grigoroiu-Serbanescu, Paul Grof, Ryota Hashimoto, Joanna Hauser, Urs Heilbronner, Stefan Herms, Per Hoffmann, Liping Hou, Yi-Hsiang Hsu, Stephane Jamain, Esther Jimenez, Jean-Pierre Kahn, Layla Kassem, Po-Hsiu Kuo, Tadafumi Kato, John Kelsoe, Sarah Kittel-Schneider, Ewa Ferensztajn-Rochowiak, Barbara Konig, Ichiro Kusumi, Gonzalo Laje, Mikael Landen, Catharina Lavebratt, Marion Leboyer, Susan G. Leckband, Mario Maj, Mirko Manchia, Lina Martinsson, Michael J. McCarthy, Susan McElroy, Francesc Colom, Marina Mitjans, Francis M. Mondimore, Palmiero Monteleone, Caroline M. Nievergelt, Markus M. Nothen, Tomas Novak, Claire O'Donovan, Norio Ozaki, Urban Osby, Sergi Papiol, Andrea Pfennig, Claudia Pisanu, James B. Potash, Andreas Reif, Eva Reininghaus, Guy A. Rouleau, Janusz K. Rybakowski, Martin Schalling, Peter R. Schofield, Barbara W. Schweizer, Giovanni Severino, Tatyana Shekhtman, Paul D. Shilling, Katzutaka Shimoda, Christian Simhandl, Claire M. Slaney, Alessio Squassina, Thomas Stamm, Pavla Stopkova, Fasil Tekola-Ayele, Alfonso Tortorella, Gustavo Turecki, Julia Veeh, Eduard Vieta, Stephanie H. Witt, Gloria Roberts, Peter P. Zandi, Martin Alda, Michael Bauer, Francis J. McMahon, Philip B. Mitchell, Thomas G. Schulze, Marcella Rietschel, Bernhard T. Baune

TRANSLATIONAL PSYCHIATRY (2022)

Article Psychiatry

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study

Hiroyuki Muraoka, Fumitoshi Kodaka, Naomi Hasegawa, Norio Yasui-Furukori, Kentaro Fukumoto, Hiroko Kashiwagi, Hiromi Tagata, Hikaru Hori, Kiyokazu Atake, Hitoshi Iida, Kayo Ichihashi, Ryuji Furihata, Takashi Tsuboi, Masahiro Takeshima, Hiroshi Komatsu, Chika Kubota, Shinichiro Ochi, Yoshikazu Takaesu, Masahide Usami, Tatsuya Nagasawa, Manabu Makinodan, Toshinori Nakamura, Mikio Kido, Ikki Ueda, Hirotaka Yamagata, Toshiaki Onitsuka, Takeshi Asami, Akitoyo Hishimoto, Kazuyoshi Ogasawara, Eiichi Katsumoto, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Katsuji Nishimura, Ryota Hashimoto

Summary: This study investigated the treatment approaches based on the severity of major depressive disorder (MDD) in real-world clinical practice. The findings revealed a decrease in the use of psychotropics with increasing severity of MDD, while a combination of antipsychotics and antidepressants and the implementation rate of modified electroconvulsive therapy (m-ECT) increased. However, the study also highlighted the existence of an evidence-practice gap in the treatment of MDD in Japan.

ASIAN JOURNAL OF PSYCHIATRY (2022)

Review Genetics & Heredity

Genetics of autism spectrum disorders and future direction

Yuka Yasuda, Junya Matsumoto, Kenichiro Miura, Naomi Hasegawa, Ryota Hashimoto

Summary: Autism spectrum disorders (ASDs) are complex genetic disorders that have been increasing in prevalence. Genetic mutations, interactions between genes and the environment, and epigenetic mechanisms all play important roles in the development and diagnosis of ASD.

JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

X chromosome aneuploidies and schizophrenia: association analysis and phenotypic characterization

Itaru Kushima, Branko Aleksic, Hiroki Kimura, Masahiro Nakatochi, Tzuyao Lo, Masashi Ikeda, Makoto Arai, Ryota Hashimoto, Shusuke Numata, Yasunobu Okamura, Taku Obara, Toshiya Inada, Norio Ozaki

Summary: This study found a significant association between 47, XXY and 47, XXX and the risk of schizophrenia. Patients with schizophrenia and 47, XXY may exhibit treatment resistance and manic symptoms.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

Letter Clinical Neurology

Association between globus pallidus volume and positive symptoms in schizophrenia

Satsuki Ito, Kenichiro Miura, Mirano Miyayama, Junya Matsumoto, Masaki Fukunaga, Keiichiro Ishimaru, Michiko Fujimoto, Yuka Yasuda, Yoshiyuki Watanabe, Ryota Hashimoto

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

Article Clinical Neurology

Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis

Takashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, Shinichiro Ochi, Kentaro Fukumoto, Kazutaka Ohi, Hiroyuki Muraoka, Tsuyoshi Okada, Funitoshi Kodaka, Shun Igarashi, Hitoshi Iida, Hiroko Kashiwagi, Hikaru Hori, Kayo Ichihashi, Kazuyoshi Ogasawara, Naoki Hashimoto, Jun-Ichi Iga, Toshinori Nakamura, Masahide Usami, Tatsuya Nagasawa, Mikio Kido, Hiroshi Komatsu, Hirotaka Yamagata, Kiyokazu Atake, Ryuji Furihata, Saya Kikuchi, Tadasu Horai, Masahiro Takeshima, Yoji Hirano, Manabu Makinodan, Junya Matsumoto, Kenichiro Miura, Akitoyo Hishimoto, Shusuke Numata, Hisashi Yamada, Norio Yasui-Furukori, Ken Inada, Koichiro Watanabe, Ryota Hashimoto

Summary: The use of electroconvulsive therapy (ECT) may reduce the need for anxiolytic and sleep medication in patients with major depressive disorder (MDD). However, there was no significant difference in anxiolytic and sleep medication use between the ECT and non-ECT groups in patients with schizophrenia (SZ).

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)

Article Neurosciences

The effect of ketamine on eye movement characteristics during free-viewing of natural images in common marmosets

Zlata Polyakova, Masao Iwase, Ryota Hashimoto, Masatoshi Yoshida

Summary: A pharmacological model of schizophrenia symptoms using a subanesthetic dose of ketamine in marmosets was used to study the effects on eye movement characteristics during free-viewing. Ketamine was found to affect saccadic eye movements in marmosets, reducing the amplitude and scanpath length of saccades while increasing the duration of saccades and fixations. These findings suggest that ketamine affects visual exploration but not the oculomotor aspect of saccades in marmosets.

FRONTIERS IN NEUROSCIENCE (2022)

暂无数据